Description
Rôles et compétences
Rôles et compétences
- Attitudes, Practices, and Perspectives of Oncology Nurses in Promoting Exercise Is Medicine Among Patients With Cancer in China: A Mixed-Methods Studyon 9 juillet 2026
Cancer Nurs. 2026 May 11. doi: 10.1097/NCC.0000000000001573. Online ahead of print.ABSTRACTBACKGROUND: The exercise is medicine (EIM) initiative, promoted as routine care for cancer populations, is […]
Formation et apprentissage
- The Lived Experiences of Grief Among Newly Graduated Oncology Nurses: A Descriptive Phenomenologic Studyon 19 juin 2026
Oncol Nurs Forum. 2026 Apr 29;53(3):1-12. doi: 10.1188/26.ONF.e26535300.ABSTRACTPURPOSE: To explore the grief experiences, influencing factors, and coping strategies of newly graduated oncology […]
Spécialités cliniques
Oncologie médicale
- Association between gut microbiota composition signature and the risk of chemotherapy-induced complications in tumor patients: a systematic review and meta-analysis...Eighth Pan-Pacific Nursing Conference cum Second Cochrane Hong Kong Symposium, March 24–28, 2026, Hong Kong SAR, China.on 21 mai 2026
International Journal of Nursing Studies; 06/02/2026(AN 193498928); ISSN: 00207489CINAHL Complete
Chirurgie oncologique
- The AMICO Clinic Approach to Integrative Oncology in Breast Cancer Care: Structure and Clinical Framework From a Southern Italian Hospitalon 16 mars 2026
Integr Cancer Ther. 2026 Jan-Dec;25:15347354251413227. doi: 10.1177/15347354251413227. Epub 2026 Feb 16.ABSTRACTWith increasing survival rates for breast cancer (BC)-91% at 5 years and 80% at 15 […]
Radio-oncologie
- Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)on 5 Décembre 2025
Oncol Rep. 2026 Feb;55(2):31. doi: 10.3892/or.2025.9036. Epub 2025 Dec 5.ABSTRACTAlternative splicing (AS) is one of the principal mechanisms of post‑transcriptional regulation that confers […]
Traitements et interventions
Traitements non-pharmacologiques
- Best evidence summary for non-pharmacological management of cancer-related fatigue in patients with prostate canceron 10 septembre 2026
Geriatr Nurs. 2026 Aug 20;73:104285. doi: 10.1016/j.gerinurse.2026.104285. Online ahead of print.ABSTRACTOBJECTIVE: To identify, appraise, and synthesize the best available evidence on […]
Approches complémentaires
- Comparative Efficacy and Safety of Traditional Chinese Medicine Injections Combined with Chemotherapy in Ovarian Cancer: A Systematic Review and Network Meta-Analysison 10 septembre 2026
J Ethnopharmacol. 2026 Sep 2:122361. doi: 10.1016/j.jep.2026.122361. Online ahead of print.ABSTRACTETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine injections (TCMIs) are widely used as […]
Réadaptation, physiothérapie et ergothérapie
- Safety and efficacy of Meridian sinew tuina (MST) for post-surgical upper limb lymphedema: a systematic review and meta-analysison 10 septembre 2026
J Obstet Gynaecol. 2026 Dec;46(1):2723314. doi: 10.1080/01443615.2026.2723314. Epub 2026 Sep 7.ABSTRACTBACKGROUND: Complex Decongestive Therapy (CDT) is the non-operative standard for breast […]
Éducation aux patients et littératie en santé
- Developing and Validating a Breast Cancer Screening Health Literacy Questionnaire Guided by Sorensen's Integrated Model for Malaysian Adultson 10 septembre 2026
Malays J Med Sci. 2026 Feb;33(1):129-144. doi: 10.21315/mjms-10-2025-719. Epub 2026 Feb 28.ABSTRACTBACKGROUND: Health literacy is essential for informed decision-making and cancer prevention. In […]
Organisation des soins
Organisation et unités de soins
- Interventional Oncology Is an Evolving Subspecialty for Oncology Nurses.on 16 février 2026
ONS Voice; 02/03/2026Although usually offered in larger, comprehensive cancer centers, IO is expanding as new discoveries and applications emerge. Many oncology nurses could come in contact with […]
Trajectoires de soins
- Nurse-Led Advance Care Planning Interventions for Patients with Advanced Cancer: A Systematic Reviewon 9 juillet 2026
Am J Hosp Palliat Care. 2026 Jun 29:10499091261464945. doi: 10.1177/10499091261464945. Online ahead of print.ABSTRACTObjectiveThis systematic review synthesizes randomized controlled trial evidence […]
Performance et indicateurs
- Evaluating Advanced Practice Nursing Implementation and Activity Indicators in Oncology and Haemato-Oncologyon 19 juin 2026
J Clin Nurs. 2026 Jun 17. doi: 10.1111/jocn.70400. Online ahead of print.ABSTRACTAIM: To describe the 2024 clinical activity of advanced practice nurses in oncology and haemato-oncology across a […]
Amélioration de la qualité et meilleures pratiques
- Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot Surveyon 16 janvier 2026
J Cancer Educ. 2026 Jan 16. doi: 10.1007/s13187-025-02823-8. Online ahead of print.NO ABSTRACTPMID:41543684 | DOI:10.1007/s13187-025-02823-8
Innovation
- Evaluation of symptom-management medications for predicting short-term survival in advanced cancer patients with machine learningon 16 février 2026
Digit Health. 2026 Feb 3;12:20552076261419945. doi: 10.1177/20552076261419945. eCollection 2026 Jan-Dec.ABSTRACTOBJECTIVE: Estimating the diverse symptoms of patients with advanced cancer is helpful […]
Expériences des patients
Expériences des patients
- Transforming Oncology Care with Electronic Patient-Reported Outcome Measures: The Christie Experience and Future Visionon 10 septembre 2026
Clin Oncol (R Coll Radiol). 2026 Jul 2;58:104285. doi: 10.1016/j.clon.2026.104285. Online ahead of print.NO ABSTRACTPMID:42594555 | DOI:10.1016/j.clon.2026.104285
Participation des patients
- Assessing the Diversity of Participants in US Colorectal Cancer Clinical Trials: A Comprehensive Review and Meta-Analysison 19 juin 2026
JCO Glob Oncol. 2026 Jun;12(6):e2500409. doi: 10.1200/GO-25-00409. Epub 2026 Jun 11.ABSTRACTPURPOSE: Colorectal cancer (CRC) is a significant health concern in the United States. Despite advancements […]
Résultats rapportés par les patients
- Patient-reported outcomes and measures applied in individuals undergoing colonoscopy surveillance for colorectal cancer: a scoping reviewon 19 juin 2026
Qual Life Res. 2026 Jun 6;35(7):170. doi: 10.1007/s11136-026-04270-4.ABSTRACTPURPOSE: Clinical guidelines recommend regular colonoscopy surveillance for individuals at elevated risk for colorectal […]
Survivance
- Cancer survivorship in malignant melanomaon 10 septembre 2026
J Dtsch Dermatol Ges. 2026 Sep;24(9):e1291-e1308. doi: 10.1111/ddg.70486x.ABSTRACTRobust long-term survival data have transformed the prognosis of metastatic melanoma. For combination therapy with […]
Publications d'associations professionnelles
Canadian Association of Nurses in Oncology (CANO/ACIO)
- Leveraging co-production in the systematic review of evidence to update the pan-Canadian Oncology Symptom Triage and Remote Support (COSTaRS) practice guideson 10 septembre 2026
Can Oncol Nurs J. 2026 Mar 1;36(2):128-139. doi: 10.5737/23688076362128. eCollection 2026.ABSTRACTWe used co-production: I) to conduct a systematic review to update the evidence on assessment, triage, and management in 17 pan-Canadian Oncology Symptom Triage and Remote Support (COSTaRS) practice guides; and II) to evaluate the co-production approach used by our team to contribute evidence on the impact of engaging knowledge users (patients, caregivers, nurses, managers, policy-makers). Of 17,618 citations, 175 were eligible, including 124 clinical practice guidelines and 51 systematic reviews with meta-analysis since the last update published in 2020. Findings were used to update the 17 COSTaRS practice guides and add one new COSTaRS practice guide for difficulty swallowing. Evidence was removed from 32 outdated sources. The COSTaRS practice guides required a few updates in the assessment, triage, medications, and self-care domains to reflect the new identified evidence. A baseline survey assessed our team members' previous experience with the COSTaRS practice guides, previous experience with conducting systematic reviews, and their preferred level of involvement for each step of the systematic review. The baseline survey yielded a response rate of 14/15 team members (93.3%). The follow-up survey including the Patient Engagement in Research Scale (PEIRS-22), completed by 12 team members (2 patient/caregivers, 5 researchers and 5 nurses), showed an extremely high level of meaningful engagement on all sub scores and the total PEIRS-22 score. Narrative feedback from participants indicated that they felt valued as equal partners and engaged through regular project updates. They enjoyed being able to select individual levels of involvement. The inclusion of multiple perspectives enhanced the richness of the final product, according to participants. While their involvement was influenced by workload time constraints, a strong sense of ownership of the final product was identified as a positive impact of the co-production process.PMID:42621903 | PMC:PMC13488159 | DOI:10.5737/23688076362128
Oncology Nursing Society (ONS)
- ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™on 13 avril 2026
ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™ Kristina M. Gantner March 31, 2026 Products in Bundle ONS Scientific Basis of Cancer™ ONS Site-Specific Cancer Considerations™ ONS Psychosocial Dimensions of Cancer Care™ ONS Care Continuum™ ONS Oncology Professional Practice™ Teaser text The ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™ provides essential, evidence‑based education aligned with the Oncology Nursing Certification Corporation (ONCC®) OCN® Test Content Outline to support certification preparation and strengthen real‑world oncology nursing practice. Member Price $290.00 Non-Member Price $240.00
American Society of Clinical Oncology (ASCO)
- Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3on 10 septembre 2026
J Clin Oncol. 2026 Aug 17:101200JCO2601958. doi: 10.1200/JCO-26-01958. Online ahead of print.ABSTRACT[Box: see text]Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website.PMID:42607282 | DOI:10.1200/JCO-26-01958
National Comprehensive Cancer Network (NCCN)
- NCCN Guidelines® Insights: Survivorship, Version 3.2026on 10 septembre 2026
J Natl Compr Canc Netw. 2026 Aug;24(8):e260039. doi: 10.6004/jnccn.2026.0039.ABSTRACTThe NCCN Guidelines for Survivorship offer guidance for health care providers who care for survivors of adult-onset cancer. These guidelines include screening, evaluation, and treatment recommendations for common physical and psychosocial problems resulting from cancer and its treatment and provide a framework for care coordination. They also present guidance for helping cancer survivors to enhance their wellness and maintain a healthy lifestyle. This article summarizes the panel's current recommendations and recent updates regarding anxiety, depression, distress, and trauma in cancer survivors.PMID:42607712 | DOI:10.6004/jnccn.2026.0039
European Society for Medical Oncology (ESMO)
- EMA Recommends Extension of Therapeutic Indications for Cetuximabon 10 septembre 2026
New indications concern the treatment of adult patients with BRAF V600E-mutated mCRC in combination with encorafenib
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


